The Beauty Health Company (NASDAQ:SKIN) Shares Purchased by Atom Investors LP

Atom Investors LP boosted its position in shares of The Beauty Health Company (NASDAQ:SKIN) by 19.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 99,924 shares of the company’s stock after buying an additional 16,416 shares during the quarter. Atom Investors LP’s holdings in Beauty Health were worth $144,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SKIN. Caprock Group LLC acquired a new position in shares of Beauty Health during the 2nd quarter worth approximately $38,000. Sanctuary Advisors LLC purchased a new stake in Beauty Health in the 2nd quarter worth $47,000. SG Americas Securities LLC acquired a new position in Beauty Health during the third quarter worth $37,000. Susquehanna Fundamental Investments LLC purchased a new position in Beauty Health during the second quarter valued at $105,000. Finally, Price T Rowe Associates Inc. MD lifted its holdings in Beauty Health by 8.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 75,281 shares of the company’s stock valued at $335,000 after purchasing an additional 5,934 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Performance

NASDAQ:SKIN opened at $1.46 on Friday. The company has a market cap of $181.22 million, a P/E ratio of -3.48 and a beta of 0.85. The Beauty Health Company has a twelve month low of $0.91 and a twelve month high of $5.17. The company’s 50-day moving average price is $1.58 and its 200-day moving average price is $1.72. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23.

Wall Street Analysts Forecast Growth

SKIN has been the subject of a number of research reports. Piper Sandler reissued an “underweight” rating and set a $1.00 target price (down previously from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Canaccord Genuity Group increased their target price on Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $2.55.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.